NOTE Fundamental Analysis - FISCALNOTE HOLDINGS INC

Fundamental Rating

Taking everything into account, NOTE scores 1 out of 10 in our fundamental rating. NOTE was compared to 86 industry peers in the Professional Services industry. NOTE has a bad profitability rating. Also its financial health evaluation is rather negative. NOTE does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year NOTE has reported negative net income.

NOTE had a negative operating cash flow in the past year.

NOTE had negative earnings in 4 of the past 5 years.

In the past 5 years NOTE always reported negative operating cash flow.

1.2 Ratios

NOTE has a worse Return On Assets (-20.36%) than 80.23% of its industry peers.

NOTE's Return On Equity of -73.85% is on the low side compared to the rest of the industry. NOTE is outperformed by 82.56% of its industry peers.

		Industry Rank	Sector Rank
ROA	-20.36%
ROE	-73.85%
ROIC	N/A

ROA(3y)-28.25%

ROA(5y)-39.12%

ROE(3y)-141.72%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

NOTE's Gross Margin of 87.25% is amongst the best of the industry. NOTE outperforms 95.35% of its industry peers.

In the last couple of years the Gross Margin of NOTE has grown nicely.

NOTE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	87.25%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y2.09%

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

NOTE does not have a ROIC to compare to the WACC, probably because it is not profitable.

NOTE has more shares outstanding than it did 1 year ago.

The debt/assets ratio for NOTE has been reduced compared to a year ago.

2.2 Solvency

NOTE has an Altman-Z score of -4.31. This is a bad value and indicates that NOTE is not financially healthy and even has some risk of bankruptcy.

NOTE has a Altman-Z score of -4.31. This is amonst the worse of the industry: NOTE underperforms 88.37% of its industry peers.

A Debt/Equity ratio of 1.66 is on the high side and indicates that NOTE has dependencies on debt financing.

Looking at the Debt to Equity ratio, with a value of 1.66, NOTE is doing worse than 79.07% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	1.66
Debt/FCF	N/A
Altman-Z	-4.31

ROIC/WACCN/A

WACC7.58%

2.3 Liquidity

NOTE has a Current Ratio of 1.01. This is a normal value and indicates that NOTE is financially healthy and should not expect problems in meeting its short term obligations.

NOTE's Current ratio of 1.01 is on the low side compared to the rest of the industry. NOTE is outperformed by 75.58% of its industry peers.

NOTE has a Quick Ratio of 1.01. This is a normal value and indicates that NOTE is financially healthy and should not expect problems in meeting its short term obligations.

The Quick ratio of NOTE (1.01) is worse than 75.58% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.01
Quick Ratio	1.01

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for NOTE have decreased strongly by -43.40% in the last year.

The Revenue for NOTE has decreased by -17.90% in the past year. This is quite bad

Measured over the past years, NOTE shows a quite strong growth in Revenue. The Revenue has been growing by 13.20% on average per year.

EPS 1Y (TTM)-43.4%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-31.06%

Revenue 1Y (TTM)-17.9%

Revenue growth 3Y13.2%

Revenue growth 5YN/A

Sales Q2Q%-23.81%

3.2 Future

NOTE is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -155.38% yearly.

The Revenue is expected to decrease by -10.38% on average over the next years. This is quite bad

EPS Next Y-646.83%

EPS Next 2Y-155.38%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year-20.13%

Revenue Next 2Y-10.38%

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NOTE. In the last year negative earnings were reported.

Also next year NOTE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

NOTE's earnings are expected to decrease with -155.38% in the coming years. This may justify a cheaper valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y-155.38%

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

NOTE does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	0%

More info and screens

Find the best dividend stocks

Show peers with best dividend

FISCALNOTE HOLDINGS INC

NYSE:NOTE (12/22/2025, 4:21:46 PM)

After market: 1.72 +0.03 (+1.78%)

1.69

-0.15 (-8.15%)

Chartmill FA Rating

GICS SectorIndustrials

GICS IndustryGroupCommercial & Professional Services

GICS IndustryProfessional Services

Earnings (Last)11-06 2025-11-06/amc

Earnings (Next)03-11 2026-03-11/bmo

Inst Owners28.64%

Inst Owner Change-91.48%

Ins Owners8.9%

Ins Owner Change-1.15%

Market Cap26.55M

Revenue(TTM)102.67M

Net Income(TTM)-55.76M

Analysts84

Price Target19.64 (1062.13%)

Short Float %14.46%

Short Ratio8.05

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0%

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)0

Avg EPS beat(2)-53.95%

Min EPS beat(2)-101.91%

Max EPS beat(2)-5.99%

EPS beat(4)1

Avg EPS beat(4)-7.88%

Min EPS beat(4)-101.91%

Max EPS beat(4)76.93%

EPS beat(8)3

Avg EPS beat(8)18.2%

EPS beat(12)5

Avg EPS beat(12)-3.52%

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)0

Avg Revenue beat(2)-1.54%

Min Revenue beat(2)-2.98%

Max Revenue beat(2)-0.09%

Revenue beat(4)1

Avg Revenue beat(4)-0.35%

Min Revenue beat(4)-2.98%

Max Revenue beat(4)2.07%

Revenue beat(8)2

Avg Revenue beat(8)-0.61%

Revenue beat(12)2

Avg Revenue beat(12)-1.34%

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)-38.89%

PT rev (3m)-38.89%

EPS NQ rev (1m)3.51%

EPS NQ rev (3m)3.51%

EPS NY rev (1m)-8.67%

EPS NY rev (3m)-1254.39%

Revenue NQ rev (1m)-2.21%

Revenue NQ rev (3m)-3.97%

Revenue NY rev (1m)-1.15%

Revenue NY rev (3m)-1.15%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.26
P/FCF	N/A
P/OCF	N/A
P/B	0.35
P/tB	N/A
EV/EBITDA	N/A

EPS(TTM)-4.13

EYN/A

EPS(NY)-2.71

Fwd EYN/A

FCF(TTM)-1.28

FCFYN/A

OCF(TTM)-0.8

OCFYN/A

SpS6.54

BVpS4.81

TBVpS-8.11

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-20.36%
ROE	-73.85%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	87.25%
FCFM	N/A

ROA(3y)-28.25%

ROA(5y)-39.12%

ROE(3y)-141.72%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y2.09%

GM growth 5YN/A

F-Score4

Asset Turnover0.37

Health

		Industry Rank	Sector Rank
Debt/Equity	1.66
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	41.35%
Cap/Sales	7.37%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	1.01
Quick Ratio	1.01
Altman-Z	-4.31

F-Score4

WACC7.58%

ROIC/WACCN/A

Cap/Depr(3y)42.35%

Cap/Depr(5y)41.75%

Cap/Sales(3y)7.79%

Cap/Sales(5y)7.7%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-43.4%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-31.06%

EPS Next Y-646.83%

EPS Next 2Y-155.38%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-17.9%

Revenue growth 3Y13.2%

Revenue growth 5YN/A

Sales Q2Q%-23.81%

Revenue Next Year-20.13%

Revenue Next 2Y-10.38%

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y13.1%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year130.96%

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y63.84%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y73.42%

OCF growth 3YN/A

OCF growth 5YN/A

FISCALNOTE HOLDINGS INC / NOTE FAQ

What is the fundamental rating for NOTE stock?

ChartMill assigns a fundamental rating of 1 / 10 to NOTE.

Can you provide the valuation status for FISCALNOTE HOLDINGS INC?

ChartMill assigns a valuation rating of 0 / 10 to FISCALNOTE HOLDINGS INC (NOTE). This can be considered as Overvalued.

How profitable is FISCALNOTE HOLDINGS INC (NOTE) stock?

FISCALNOTE HOLDINGS INC (NOTE) has a profitability rating of 1 / 10.

What is the expected EPS growth for FISCALNOTE HOLDINGS INC (NOTE) stock?

The Earnings per Share (EPS) of FISCALNOTE HOLDINGS INC (NOTE) is expected to decline by -646.83% in the next year.

FISCALNOTE HOLDINGS INC (NOTE) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

FISCALNOTE HOLDINGS INC / NOTE FAQ

What is the fundamental rating for NOTE stock?

Can you provide the valuation status for FISCALNOTE HOLDINGS INC?

How profitable is FISCALNOTE HOLDINGS INC (NOTE) stock?

What is the expected EPS growth for FISCALNOTE HOLDINGS INC (NOTE) stock?